Michelin, Forvia, Stellantis Finalize Symbio Restructuring Agreement
Michelin, Forvia, and Stellantis have solidified a restructuring agreement concerning their hydrogen fuel cell enterprise, Symbio. This announcement, made public on December 3, 2025, comes after Stellantis’ decision to halt its hydrogen fuel cell technology program in July, which significantly impacted Symbio as it accounted for 80% of the company’s business volume.
Restructuring Details
The partnership among Michelin, Forvia, and Stellantis remains steadfast, with each entity holding an equal stake of 33% in Symbio. However, the recent developments have necessitated a reassessment of Symbio’s operational strategy.
Workforce Reduction
As part of this restructuring effort, Symbio has announced plans to decrease its workforce from 650 employees to 175. This drastic reduction reflects the need to align the company’s operations with its revised scope.
Production Goals
Despite the setbacks, Symbio aims to achieve a production capacity of 10,000 hydrogen fuel cell systems annually by the 2028-2030 timeframe. This target will be met at the SymphonHy facility located in Saint-Fons, a key asset for the company’s future.
- Key Players: Michelin, Forvia, Stellantis
- Workforce Reduction: From 650 to 175 employees
- Production Goal: 10,000 systems per year
- Production Site: SymphonHy, Saint-Fons
The agreements made will guide Symbio through its transition, ensuring that it can remain viable within the evolving hydrogen fuel cell market. Each partner is committed to achieving sustainable growth in this crucial sector.
